Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot P03313 (POLG_CXB3N)

Last modified June 16, 2009. Version 111. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (3) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Genome polyprotein
Cleaved into the following 12 chains:
    1- Recommended name:
            Protein VP0
        Alternative name(s):
            VP4-VP2
    2- Recommended name:
            Protein VP4
        Alternative name(s):
            Virion protein 4
            P1A
    3- Recommended name:
            Protein VP2
        Alternative name(s):
            Virion protein 2
            P1B
    4- Recommended name:
            Protein VP3
        Alternative name(s):
            Virion protein 3
            P1C
    5- Recommended name:
            Protein VP1
        Alternative name(s):
            Virion protein 1
            P1D
    6- Recommended name:
            Picornain 2A
                Short name=Protein 2A
                Short name=P2A
              EC=3.4.22.29
    7- Recommended name:
            Protein 2B
                Short name=P2B
    8- Recommended name:
            Protein 2C
                Short name=P2C
              EC=3.6.1.15
    9- Recommended name:
            Protein 3A
                Short name=P3A
    10- Recommended name:
            Protein 3B
                Short name=P3B
        Alternative name(s):
            VPg
    11- Recommended name:
            Picornain 3C
              EC=3.4.22.28
        Alternative name(s):
            Protease 3C
              Short name=P3C
    12- Recommended name:
            RNA-directed RNA polymerase 3D-POL
                Short name=P3D-POL
              EC=2.7.7.48
OrganismCoxsackievirus B3 (strain Nancy) [Complete proteome]
Taxonomic identifier103903 [NCBI]
Taxonomic lineageVirusesssRNA positive-strand viruses, no DNA stagePicornaviralesPicornaviridaeEnterovirus
Virus hostHomo sapiens (Human) [TaxID: 9606]

Protein attributes

Sequence length2185 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Capsid proteins VP1, VP2, VP3 and VP4 form a closed capsid enclosing the viral positive strand RNA genome. VP4 lies on the inner surface of the protein shell formed by VP1, VP2 and VP3. All the three latter proteins contain a beta-sheet structure called beta-barrel jelly roll. Together they form an icosahedral capsid (T=3) composed of 60 copies of each VP1, VP2, and VP3, with a diameter of approximately 300 Angstroms. VP1 is situated at the 12 fivefold axes, whereas VP2 and VP3 are located at the quasi-sixfold axes By similarity. Capsid proteins interact with host CAR/CXADR or CD55 to provide virion attachment to target cell.

VP0 precursor is a component of immature procapsids By similarity.

Protein 2A is a cysteine protease that is responsible for the cleavage between the P1 and P2 regions. It cleaves the host translation initiation factor EIF4G1, in order to shut down the capped cellular mRNA transcription By similarity.

Protein 2B affects membrane integrity and cause an increase in membrane permeability By similarity.

Protein 2C associates with and induces structural rearrangements of intracellular membranes. It displays RNA-binding, nucleotide binding and NTPase activities By similarity.

Protein 3A, via its hydrophobic domain, serves as membrane anchor By similarity. It also inhibits endoplasmic reticulum-to-Golgi transport By similarity.

Protein 3C is a cysteine protease that generates mature viral proteins from the precursor polyprotein. In addition to its proteolytic activity, it binds to viral RNA, and thus influences viral genome replication. RNA and substrate bind co-operatively to the protease By similarity.

RNA-directed RNA polymerase 3D-POL replicates genomic and antigenomic RNA by recognizing replications specific signals By similarity.

Catalytic activity

Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).

Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein.

Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.

NTP + H2O = NDP + phosphate.

Subunit structure

Capsid proteins interact with host CD55 and CXADR.

Subcellular location

Protein VP2: Virion. Host cytoplasm Potential.

Protein VP3: Virion. Host cytoplasm Potential.

Protein VP1: Virion. Host cytoplasm Potential.

Protein 2B: Host cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side Potential. Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum By similarity.

Protein 2C: Host cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side Potential. Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum By similarity.

Protein 3A: Host cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side Potential. Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum By similarity.

Protein 3B: Virion Potential.

Picornain 3C: Host cytoplasm Potential.

RNA-directed RNA polymerase 3D-POL: Host cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side Potential. Note: Probably localizes to the surface of intracellular membrane vesicles that are induced after virus infection as the site for viral RNA replication. These vesicles are derived from the endoplasmic reticulum By similarity.

Post-translational modification

Specific enzymatic cleavages in vivo by the viral proteases yield a variety of precursors and mature proteins. Polyprotein processing intermediates such as VP0 which is a VP4-VP2 precursor are produced. During virion maturation, non-infectious particles are rendered infectious following cleavage of VP0. This maturation cleavage is followed by a conformational change of the particle By similarity.

VPg is uridylylated by the polymerase and is covalently linked to the 5'-end of genomic RNA. This uridylylated form acts as a nucleotide-peptide primer for the polymerase By similarity.

Myristoylation of VP4 is required during RNA encapsidation and formation of the mature virus particle By similarity.

Sequence similarities

Belongs to the picornaviruses polyprotein family.

Contains 2 peptidase C3 domains.

Contains 1 RdRp catalytic domain.

Contains 1 SF3 helicase domain.

Ontologies

Keywords
   Biological processHost-virus interaction
RNA replication
   Cellular componentCapsid protein
Cytoplasm
Cytoplasmic vesicle
Membrane
Virion
   LigandATP-binding
Nucleotide-binding
RNA-binding
   Molecular functionHelicase
Hydrolase
Nucleotidyltransferase
Protease
RNA-directed RNA polymerase
Thiol protease
Transferase
   PTMCovalent protein-RNA linkage
Lipoprotein
Myristate
Phosphoprotein
   Technical term3D-structure
Complete proteome
Gene Ontology (GO)
   Biological processRNA-protein covalent cross-linking

Inferred from electronic annotation. Source: UniProtKB-KW

interspecies interaction between organisms

Inferred from electronic annotation. Source: UniProtKB-KW

proteolysis

Inferred from electronic annotation. Source: InterPro

transcription, RNA-dependent

Inferred from electronic annotation. Source: UniProtKB-KW

viral genome replication

Inferred from electronic annotation. Source: InterPro

   Cellular componentcytoplasmic vesicle

Inferred from electronic annotation. Source: UniProtKB-KW

host cell cytoplasm

Inferred from electronic annotation. Source: UniProtKB-SubCell

membrane

Inferred from electronic annotation. Source: UniProtKB-KW

viral capsid

Inferred from electronic annotation. Source: UniProtKB-KW

   Molecular functionATP binding

Inferred from electronic annotation. Source: UniProtKB-KW

RNA binding

Inferred from electronic annotation. Source: UniProtKB-KW

RNA helicase activity

Inferred from electronic annotation. Source: InterPro

RNA-directed RNA polymerase activity

Inferred from electronic annotation. Source: UniProtKB-KW

cysteine-type endopeptidase activity

Inferred from electronic annotation. Source: InterPro

structural molecule activity

Inferred from electronic annotation. Source: UniProtKB-KW

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Initiator methionine11Removed; by host By similarity
Chain2 – 332331Protein VP0 Potential
PRO_0000311047
Chain2 – 6968Protein VP4 Potential
PRO_0000039582
Chain70 – 332263Protein VP2 Potential
PRO_0000039583
Chain333 – 570238Protein VP3 Potential
PRO_0000039584
Chain571 – 851281Protein VP1 Potential
PRO_0000039585
Chain852 – 1001150Picornain 2A Potential
PRO_0000039586
Chain1002 – 110099Protein 2B Potential
PRO_0000039587
Chain1101 – 1429329Protein 2C Potential
PRO_0000039588
Chain1430 – 151889Protein 3A Potential
PRO_0000039589
Chain1519 – 154022Protein 3B Potential
PRO_0000039590
Chain1541 – 1723183Picornain 3C Potential
PRO_0000039591
Chain1724 – 2185462RNA-directed RNA polymerase 3D-POL Potential
PRO_0000039592

Regions

Topological domain2 – 14951494Cytoplasmic Potential
Topological domain1496 – 151116In membrane Potential
Topological domain1512 – 2185674Cytoplasmic Potential
Domain1205 – 1361157SF3 helicase
Domain1950 – 2066117RdRp catalytic
Nucleotide binding1229 – 12368ATP Potential

Sites

Active site8721For picornain 2A activity By similarity
Active site8901For picornain 2A activity By similarity
Active site9611For picornain 2A activity By similarity
Active site15801For picornain 3C activity Potential
Active site16111For picornain 3C activity Potential
Active site16871For picornain 3C activity By similarity
Site69 – 702Cleavage Potential
Site332 – 3332Cleavage; by picornain 3C Potential
Site851 – 8522Cleavage; by picornain 2A Potential
Site1001 – 10022Cleavage; by picornain 3C Potential
Site1100 – 11012Cleavage; by picornain 3C Potential
Site1429 – 14302Cleavage; by picornain 3C Potential
Site1518 – 15192Cleavage; by picornain 3C Potential
Site1540 – 15412Cleavage; by picornain 3C Potential
Site1723 – 17242Cleavage; by picornain 3C Potential

Amino acid modifications

Modified residue15211O-(5'-phospho-RNA)-tyrosine By similarity
Lipidation21N-myristoyl glycine; by host By similarity

Experimental info

Sequence conflict161R → G in AAA74400. Ref.2
Sequence conflict1771V → D in AAA74400. Ref.2
Sequence conflict4691P → L in AAA74400. Ref.2
Sequence conflict4871I → V in AAA74400. Ref.2
Sequence conflict5101F → Y in AAA74400. Ref.2
Sequence conflict5161Y → C in AAA74400. Ref.2
Sequence conflict5661Q → E in AAA74400. Ref.2
Sequence conflict5931T → N in AAA74400. Ref.2
Sequence conflict6501K → E in AAA74400. Ref.2
Sequence conflict854 – 86512FGQQS…VYVGN → IWTTIRGSVCGD in AAA74400. Ref.2
Sequence conflict8731L → S in AAA74400. Ref.2
Sequence conflict10971A → P in AAA74400. Ref.2
Sequence conflict12801Q → H in AAA74400. Ref.2
Sequence conflict14371I → F in AAA74400. Ref.2
Sequence conflict15031V → M in AAA74400. Ref.2
Sequence conflict16161K → E in AAA74400. Ref.2
Sequence conflict16241R → G in AAA74400. Ref.2
Sequence conflict16271R → G in AAA74400. Ref.2
Sequence conflict16301L → V in AAA74400. Ref.2
Sequence conflict17181Y → N in AAA74400. Ref.2
Sequence conflict17341D → V in AAA74400. Ref.2
Sequence conflict17581E → V Ref.2
Sequence conflict17581E → V Ref.3
Sequence conflict18241V → R Ref.2
Sequence conflict18241V → R Ref.3
Sequence conflict18671C → R Ref.2
Sequence conflict18671C → R Ref.3
Sequence conflict18801Y → H Ref.2
Sequence conflict18801Y → H Ref.3
Sequence conflict20011D → N Ref.2
Sequence conflict20011D → N Ref.3
Sequence conflict20951A → V Ref.2
Sequence conflict20951A → V Ref.3
Sequence conflict21151V → A Ref.2
Sequence conflict21151V → A Ref.3
Sequence conflict21751S → T Ref.2
Sequence conflict21751S → T Ref.3
Sequence conflict21781R → G Ref.2
Sequence conflict21781R → G Ref.3

Secondary structure

................................................................................................................................................................... 2185
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
P03313-1 [UniParc].

Last modified January 23, 2007. Version 4.
Checksum: 1B5ECE3DA47338FF

FASTA2,185243,453
        10         20         30         40         50         60 
MGAQVSTQKT GAHETRLNAS GNSIIHYTNI NYYKDAASNS ANRQDFTQDP GKFTEPVKDI 

        70         80         90        100        110        120 
MIKSLPALNS PTVEECGYSD RARSITLGNS TITTQECANV VVGYGVWPDY LKDSEATAED 

       130        140        150        160        170        180 
QPTQPDVATC RFYTLDSVQW QKTSPGWWWK LPDALSNLGL FGQNMQYHYL GRTGYTVHVQ 

       190        200        210        220        230        240 
CNASKFHQGC LLVVCVPEAE MGCATLDNTP SSAELLGGDT AKEFADKPVA SGSNKLVQRV 

       250        260        270        280        290        300 
VYNAGMGVGV GNLTIFPHQW INLRTNNSAT IVMPYTNSVP MDNMFRHNNV TLMVIPFVPL 

       310        320        330        340        350        360 
DYCPGSTTYV PITVTIAPMC AEYNGLRLAG HQGLPTMNTP GSCQFLTSDD FQSPSAMPQY 

       370        380        390        400        410        420 
DVTPEMRIPG EVKNLMEIAE VDSVVPVQNV GEKVNSMEAY QIPVRSNEGS GTQVFGFPLQ 

       430        440        450        460        470        480 
PGYSSVFSRT LLGEILNYYT HWSGSIKLTF MFCGSAMATG KFLLAYSPPG AGAPTKRVDA 

       490        500        510        520        530        540 
MLGTHVIWDV GLQSSCVLCI PWISQTHYRF VASDEYTAGG FITCWYQTNI VVPADAQSSC 

       550        560        570        580        590        600 
YIMCFVSACN DFSVRLLKDT PFISQQNFFQ GPVEDAITAA IGRVADTVGT GPTNSEAIPA 

       610        620        630        640        650        660 
LTAAETGHTS QVVPGDTMQT RHVKNYHSRS ESTIENFLCR SACVYFTEYK NSGAKRYAEW 

       670        680        690        700        710        720 
VLTPRQAAQL RRKLEFFTYV RFDLELTFVI TSTQQPSTTQ NQDAQILTHQ IMYVPPGGPV 

       730        740        750        760        770        780 
PDKVDSYVWQ TSTNPSVFWT EGNAPPRMSI PFLSIGNAYS NFYDGWSEFS RNGVYGINTL 

       790        800        810        820        830        840 
NNMGTLYARH VNAGSTGPIK STIRIYFKPK HVKAWIPRPP RLCQYEKAKN VNFQPSGVTT 

       850        860        870        880        890        900 
TRQSITTMTN TGAFGQQSGA VYVGNYRVVN RHLATSADWQ NCVWESYNRD LLVSTTTAHG 

       910        920        930        940        950        960 
CDIIARCQCT TGVYFCASKN KHYPISFEGP GLVEVQESEY YPRRYQSHVL LAAGFSEPGD 

       970        980        990       1000       1010       1020 
CGGILRCEHG VIGIVTMGGE GVVGFADIRD LLWLEDDAME QGVKDYVEQL GNAFGSGFTN 

      1030       1040       1050       1060       1070       1080 
QICEQVNLLK ESLVGQDSIL EKSLKALVKI ISALVIVVRN HDDLITVTAT LALIGCTSSP 

      1090       1100       1110       1120       1130       1140 
WRWLKQKVSQ YYGIPMAERQ NNSWLKKFTE MTNACKGMEW IAVKIQKFIE WLKVKILPEV 

      1150       1160       1170       1180       1190       1200 
REKHEFLNRL KQLPLLESQI ATIEQSAPSQ SDQEQLFSNV QYFAHYCRKY APLYAAEAKR 

      1210       1220       1230       1240       1250       1260 
VFSLEKKMSN YIQFKSKCRI EPVCLLLHGS PGAGKSVATN LIGRSLAEKL NSSVYSLPPD 

      1270       1280       1290       1300       1310       1320 
PDHFDGYKQQ AVVIMDDLCQ NPDGKDVSLF CQMVSSVDFV PPMAALEEKG ILFTSPFVLA 

      1330       1340       1350       1360       1370       1380 
STNAGSINAP TVSDSRALAR RFHFDMNIEV ISMYSQNGKI NMPMSVKTCD DECCPVNFKK 

      1390       1400       1410       1420       1430       1440 
CCPLVCGKAI QFIDRRTQVR YSLDMLVTEM FREYNHRHSV GTTLEALFQG PPVYREIKIS 

      1450       1460       1470       1480       1490       1500 
VAPETPPPPA IADLLKSVDS EAVREYCKEK GWLVPEINST LQIEKHVSRA FICLQALTTF 

      1510       1520       1530       1540       1550       1560 
VSVAGIIYII YKLFAGFQGA YTGVPNQKPR VPTLRQAKVQ GPAFEFAVAM MKRNSSTVKT 

      1570       1580       1590       1600       1610       1620 
EYGEFTMLGI YDRWAVLPRH AKPGPTILMN DQEVGVLDAK ELVDKDGTNL ELTLLKLNRN 

      1630       1640       1650       1660       1670       1680 
EKFRDIRGFL AKEEVEVNEA VLAINTSKFP NMYIPVGQVT EYGFLNLGGT PTKRMLMYNF 

      1690       1700       1710       1720       1730       1740 
PTRAGQCGGV LMSTGKVLGI HVGGNGHQGF SAALLKHYFN DEQGEIEFIE SSKDAGFPVI 

      1750       1760       1770       1780       1790       1800 
NTPSKTKLEP SVFHQVFEGN KEPAVLRSGD PRLKANFEEA IFSKYIGNVN THVDEYMLEA 

      1810       1820       1830       1840       1850       1860 
VDHYAGQLAT LDISTEPMKL EDAVYGTEGL EALDLTTSAG YPYVALGIKK RDILSKKTKD 

      1870       1880       1890       1900       1910       1920 
LTKLKECMDK YGLNLPMVTY VKDELRSIEK VAKGKSRLIE ASSLNDSVAM RQTFGNLYKT 

      1930       1940       1950       1960       1970       1980 
FHLNPGVVTG SAVGCDPDLF WSKIPVMLDG HLIAFDYSGY DASLSPVWFA CLKMLLEKLG 

      1990       2000       2010       2020       2030       2040 
YTHKETNYID YLCNSHHLYR DKHYFVRGGM PSGCSGTSIF NSMINNIIIR TLMLKVYKGI 

      2050       2060       2070       2080       2090       2100 
DLDQFRMIAY GDDVIASYPW PIDASLLAEA GKGYGLIMTP ADKGECFNEV TWTNATFLKR 

      2110       2120       2130       2140       2150       2160 
YFRADEQYPF LVHPVMPMKD IHESIRWTKD PKNTQDHVRS LCLLAWHNGE HEYEEFIRKI 

      2170       2180 
RSVPVGRCLT LPAFSTLRRK WLDSF 

« Hide

References

[1]"Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis."
Klump W.M., Bergmann I., Mueller B.C., Ameis D., Kandolf R.
J. Virol. 64:1573-1583(1990) [PubMed: 2157045] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA].
[2]"Genome of coxsackievirus B3."
Lindberg A.M., Staalhandske P.O.K., Pettersson U.
Virology 156:50-63(1987) [PubMed: 3027968] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA].
[3]"Replicase gene of coxsackievirus B3."
Staalhandske P.O.K., Lindberg A.M., Pettersson U.
J. Virol. 51:742-746(1984) [PubMed: 6088796] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1724-2185.
[4]"Coxsackieviruses B1, B3, and B5 use decay aCCelerating factor as a receptor for cell attachment."
Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., Barry R.D.
J. Virol. 69:3873-3877(1995) [PubMed: 7538177] [Abstract]
Cited for: INTERACTION WITH HOST CD55.
[5]"The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus."
Martino T.A., Petric M., Weingartl H., Bergelson J.M., Opavsky M.A., Richardson C.D., Modlin J.F., Finberg R.W., Kain K.C., Willis N., Gauntt C.J., Liu P.P.
Virology 271:99-108(2000) [PubMed: 10814575] [Abstract]
Cited for: INTERACTION WITH HOST CXADR.
[6]"Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment."
Wessels E., Duijsings D., Lanke K.H., van Dooren S.H., Jackson C.L., Melchers W.J., van Kuppeveld F.J.
J. Virol. 80:11852-11860(2006) [PubMed: 17005635] [Abstract]
Cited for: FUNCTION OF PROTEIN 3A.
[7]"Structure determination of coxsackievirus B3 to 3.5-A resolution."
Muckelbauer J.K., Kremer M., Minor I., Tong L., Zlotnick A., Johnson J.E., Rossmann M.G.
Acta Crystallogr. D 51:871-887(1995) [PubMed: 15299757] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 1-851.
+Additional computationally mapped references.

Cross-references

Sequence databases

M33854 Genomic RNA. Translation: AAA42931.1.
K02709 Genomic RNA. Translation: AAA42932.1.
M16572 Genomic RNA. Translation: AAA74400.1.
PIRGNNYB3. A26354.
GNNYBT. A34664.

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1COVX-ray3.504-[»]
2VB0X-ray2.40A1541-1723[»]
2ZTXX-ray1.72A1541-1723[»]
2ZTYX-ray1.72A1541-1723[»]
2ZTZX-ray2.00A/B1541-1723[»]
2ZU1X-ray1.38A/B1541-1723[»]
2ZU3X-ray1.75A1541-1723[»]
3CDUX-ray2.10A1724-2185[»]
3CDWX-ray2.50A1724-2185[»]
H1519-1540[»]
ModBaseSearch...

Protein family/group databases

MEROPSC03.011.

Family and domain databases

InterProIPR003593. ATPase_AAA+_core.
IPR004004. Helicase/Pol/Pept_Calicivir.
IPR000605. Helicase_SF3_ssDNA/RNA_vir.
IPR014759. Helicase_SF3_ssRNA_vir.
IPR014838. P3A.
IPR000199. Pept_C3_picorn.
IPR000081. Peptidase_C3.
IPR003138. Pico_P1A.
IPR002527. Pico_P2B.
IPR001676. Picornavirus_capsid.
IPR001205. RNA_pol_P3D.
IPR007094. RNA_pol_PSvir.
[Graphical view]
PfamPF08727. P3A. 1 hit.
PF00548. Peptidase_C3. 1 hit.
PF02226. Pico_P1A. 1 hit.
PF00947. Pico_P2A. 1 hit.
PF01552. Pico_P2B. 1 hit.
PF00680. RdRP_1. 1 hit.
PF00073. Rhv. 3 hits.
PF00910. RNA_helicase. 1 hit.
[Graphical view]
PRINTSPR00918. CALICVIRUSNS.
ProDomPD001125. Pept_C3_picorn. 1 hit.
PD001306. Peptidase_C3_2. 1 hit.
PD001274. Pico_P2B. 1 hit.
[Graphical view] [Entries sharing at least one domain]
SMARTSM00382. AAA. 1 hit.
[Graphical view]
PROSITEPS50507. RDRP_SSRNA_POS. 1 hit.
PS51218. SF3_HELICASE_2. 1 hit.
[Graphical view]
ProtoNetSearch...

Entry information

Entry namePOLG_CXB3N
AccessionPrimary (citable) accession number: P03313
Secondary accession number(s): Q66322 expand/collapse secondary AC list , Q66323, Q66324, Q66325, Q66326, Q66327, Q66328, Q83744
Entry history
Integrated into UniProtKB/Swiss-Prot: July 21, 1986
Last sequence update: January 23, 2007
Last modified: June 16, 2009
This is version 111 of the entry and version 4 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectVirus (Virus annotation project)

Relevant documents

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

Peptidase families

Classification of peptidase families and list of entries

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents